paroxetine has been researched along with Cardiac Remodeling, Ventricular in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glumac, S; Japundžić-Žigon, N; Kosić, M; Nešić, Z; Pajović, V; Savić, B; Vasić, M | 1 |
| Babongo Bosombo, F; Deckarm, S; Dobner, S; Erne, SA; Fischer, K; Fürholz, M; Gräni, C; Heg, D; Hunziker, L; Lanz, J; Pilgrim, T; Reusser, N; Siontis, GCM; Stark, AW; Stortecky, S; Vollenbroich, R; Windecker, S | 1 |
| Bøtker, HE; Johnsen, J; Kristiansen, SB; Lassen, TR; Nielsen, JM; Ringgaard, S | 1 |
| Chen, X; Chuprun, JK; Feldman, AM; Gao, E; Koch, WJ; Schumacher, SM; Tesmer, JJ; Zhu, W | 1 |
1 trial(s) available for paroxetine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effect of Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition vs Placebo in Patients With Anterior Myocardial Infarction: A Randomized Clinical Trial.
Topics: Anterior Wall Myocardial Infarction; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Paroxetine; Prognosis; Retrospective Studies; ST Elevation Myocardial Infarction; Ventricular Remodeling | 2021 |
3 other study(ies) available for paroxetine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Paroxetine mitigates cardiac remodelling by doxorubicin and increases survival.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Gene Expression Regulation; Male; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Ventricular Remodeling | 2022 |
Effect of paroxetine on left ventricular remodeling in an in vivo rat model of myocardial infarction.
Topics: Animals; Antioxidants; Echocardiography; Magnetic Resonance Imaging; Male; Myocardial Infarction; Paroxetine; Rats; Rats, Wistar; Reactive Oxygen Species; Selective Serotonin Reuptake Inhibitors; Ventricular Remodeling | 2017 |
Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Fibrosis; G-Protein-Coupled Receptor Kinase 2; Heart Failure; Hemodynamics; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Paroxetine; Receptors, Adrenergic, beta; Translational Research, Biomedical; Ventricular Remodeling | 2015 |